R. Gurny

R. Gurny, M. Fathi, V. Kaltsatos, 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections.

L. Balant, J. Veuthey, R. Gurny, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation

R. Gurny, F. Gurtler, V. Kaltsatos, 1995 .

Bioadhesive Intraoral Release Systems

R. Gurny, 1986 .

Controlled drug release from melt-extrudates through processing parameters: a chemometric approach.

S. Cherkaoui, R. Gurny, E. Doelker, 2015, International journal of pharmaceutics.

Biodegradable nanoparticles — From sustained release formulations to improved site specific drug delivery

R. Gurny, J. Leroux, E. Allémann, 1996 .

Aqueous nanodispersions prepared by a salting-out process

R. Gurny, E. Doelker, P. Buri, 1992 .

Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles.

Robert Gurny, Eric Allémann, R. Gurny, 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

In Vitro Extended-Release Properties of Drug-Loaded Poly(DL-Lactic Acid) Nanoparticles Produced by a Salting-Out Procedure

R. Gurny, J. Leroux, E. Allémann, 1993, Pharmaceutical Research.

Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell Uptake

J. Feijen, R. Gurny, J. Leroux, 1999, Pharmaceutical Research.

Toward the understanding of the photodynamic activity of m-THPP encapsulated in PLGA nanoparticles: correlation between nanoparticle properties and in vivo activity

R. Gurny, R. Černý, T. Arvinte, 2009, Journal of drug targeting.

An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes.

R. Gurny, J. Leroux, J. Leroux, 1995, Life sciences.

Cellular Uptake of PEO Surface-Modified Nanoparticles: Evaluation of Nanoparticles Made of PLA: PEO Diblock and Triblock Copolymers

J. Feijen, R. Gurny, T. Kissel, 2000, Journal of drug targeting.

New approach for the preparation of nanoparticles by an emulsification-diffusion method

R. Gurny, J. Leroux, E. Allémann, 1995 .

Self‐assembling polymeric nanocarriers to target inflammatory lesions in ulcerative colitis

R. Gurny, M. Möller, Herve Courthion, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Evaluation of nanoparticle tracking analysis (NTA) in the characterization of therapeutic antibodies and seasonal influenza vaccines: pros and cons

R. Gurny, T. Arvinte, E. Patois, 2012 .

Poly(ortho esters): synthesis, characterization, properties and uses.

Robert Gurny, Jorge Heller, John Barr, 2002, Advanced drug delivery reviews.

pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs

R. Gurny, R. Černý, E. Allémann, 2001, AAPS PharmSci.

Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state.

R. Gurny, R. Cozens, E. Allémann, 2000, Journal of controlled release : official journal of the Controlled Release Society.

Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systems.

Joerg Ogorka, R. Gurny, H. Metz, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Histologic Assessment of Drug-Eluting Grafts Related to Implantation Site

R. Gurny, B. Nottelet, D. Mandracchia, 2016, Journal of developmental biology.

Fully biodegradable polymeric micelles based on hydrophobic‐ and hydrophilic‐functionalized poly(lactide) block copolymers

R. Gurny, B. Nottelet, M. Möller, 2010 .

Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.

Maria Angela Vandelli, Robert Gurny, Luca Costantino, 2006, Biomaterials.

Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.

R. Gurny, F. Behar-Cohen, J. Jeanny, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Near Infrared with Principal Component Analysis as a Novel Analytical Approach for Nanoparticle Technology

R. Gurny, P. Couvreur, I. Brigger, 2000, Pharmaceutical Research.

Preparation of aqueous polymeric nanodispersions by a reversible salting-out process : influence of process parameters on particle size

R. Gurny, E. Allémann, E. Doelker, 1992 .

Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles.

R. Gurny, E. Allémann, F. Delié, 2001, International journal of pharmaceutics.

Screening of nanoparticulate delivery systems for the photodetection of cancer in a simple and cost-effective model.

R. Gurny, N. Lange, F. Delié, 2009, Nanomedicine.

Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating

R. Gurny, D. Quintanar-Guerrero, H. Fessi, 2006, AAPS PharmSciTech.

Thermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervix.

Q. Peng, R. Gurny, N. Lange, 2008, Journal of pharmaceutical sciences.

Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus.

R. Gurny, N. Lange, T. Warloe, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Efficacy study of two novel hyaluronic acid-based formulations for viscosupplementation therapy in an early osteoarthrosic rabbit model.

R. Gurny, L. Scapozza, M. Möller, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Soft X‐ray microscopy for probing of topical tacrolimus delivery via micelles

R. Gurny, P. Schrade, S. Bachmann, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants.

Robert Gurny, Pascal Furrer, R. Gurny, 2000, International journal of pharmaceutics.

A novel cyclosporin a aqueous formulation for dry eye treatment: in vitro and in vivo evaluation.

R. Gurny, F. Behar-Cohen, M. Möller, 2012, Investigative ophthalmology & visual science.

Nanotechnology and Regenerative Medicine A Novel Cyclosporin A Aqueous Formulation for Dry Eye Treatment : In Vitro and In Vivo Evaluation

R. Gurny, F. Behar-Cohen, M. Möller, 2012 .

In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.

J. Veuthey, S. Rudaz, D. Guillarme, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Colloidal systems for the delivery of cyclosporin A to the anterior segment of the eye.

R. Gurny, F. Behar-Cohen, M. Möller, 2011, Annales pharmaceutiques francaises.

Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size.

R. Gurny, M. Gaumet, F. Delié, 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways.

Y. Kalia, R. Gurny, L. Scapozza, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Intraocular implants for extended drug delivery: therapeutic applications.

R. Gurny, F. Behar-Cohen, A. Bochot, 2006, Advanced drug delivery reviews.

Biodegradable scleral implants as new triamcinolone acetonide delivery systems.

R. Gurny, S. Eperon, Y. Guex-Crosier, 2006, International journal of pharmaceutics.

Cyclosporine A delivery to the eye: a pharmaceutical challenge.

R. Gurny, F. Behar-Cohen, F. Lallemand, 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer Nanoparticles

J. Feijen, R. Gurny, T. Kissel, 2000, Pharmaceutical development and technology.

Bioadhesive intraoral release systems: design, testing and analysis.

N. Peppas, N. Peppas, R. Gurny, 1984, Biomaterials.

Modelling of sustained release of water-soluble drugs from porous, hydrophobic polymers.

N. Peppas, R. Gurny, E. Doelker, 1982, Biomaterials.

Osmotically controlled drug delivery systems produced from organic solutions and aqueous dispersions of cellulose acetate

R. Gurny, E. Doelker, C. Bindschaedler, 1986 .

Design and development of controlled release veterinary drug delivery systems to the eye

R. Gurny, F. Behar-Cohen, O. Felt, 2000 .

The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation.

R. Gurny, A. Rougemont, B. Walpoth, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Stability of seasonal influenza vaccines investigated by spectroscopy and microscopy methods.

R. Gurny, T. Arvinte, E. Patois, 2011, Vaccine.

Internalization of poly(D,L-lactic acid) nanoparticles by isolated human leukocytes and analysis of plasma proteins adsorbed onto the particles.

L. Balant, R. Gurny, J. Leroux, 1994, Journal of biomedical materials research.

Development of soft nanocarriers from novel amphiphilic hyaluronic acid derivatives towards drug delivery

R. Gurny, E. Stenby, G. Kontogeorgis, 2008 .

Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes.

R. Gurny, N. Lange, M. Campo, 2007, Bioconjugate chemistry.

Poly-Lactic Acid-Based Biopolymer Formulations Are Safe for Sustained Intratympanic Dexamethasone Delivery.

K. Krause, R. Gurny, P. Senn, 2019, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

Influence of methionine oxidation on the aggregation of recombinant human growth hormone.

R. Gurny, T. Arvinte, M. Capelle, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Identification of aggregation breakers for bevacizumab (Avastin®) self-association through similarity searching and interaction studies.

R. Gurny, L. Scapozza, T. Riis-Johannessen, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Synergies of VEGF inhibition and photodynamic therapy in the treatment of age-related macular degeneration.

R. Gurny, C. Mailhos, D. Shima, 2007, Investigative ophthalmology & visual science.

Quenching-induced deactivation of photosensitizer by nanoencapsulation to improve phototherapy of cancer

R. Gurny, N. Lange, M. Zeisser-Labouèbe, 2009, Journal of drug targeting.

Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles)

V. H. Lee, R. Gurny, J. Himber, 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

Thrombin-sensitive dual fluorescence imaging and therapeutic agent for detection and treatment of synovial inflammation in murine rheumatoid arthritis.

R. Gurny, N. Lange, M. Zuluaga, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applications.

R. Gurny, J. Tille, B. Walpoth, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Kinetics of blood component adsorption on poly(D,L-lactic acid) nanoparticles: evidence of complement C3 component involvement.

L. Balant, R. Gurny, J. Leroux, 1997, Journal of biomedical materials research.

In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymer.

R. Gurny, J. Tille, M. Möller, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.

Y. Kalia, R. Gurny, M. Möller, 2014, Molecular pharmaceutics.

Biotolerance of a semisolid hydrophobic biodegradable poly(ortho ester) for controlled drug delivery.

R. Gurny, J. Anderson, J. Heller, 1993, Journal of biomedical materials research.

Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts

R. Gurny, F. Lallemand, S. Benita, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

New generation of poly(ortho esters) : synthesis, characterization, kinetics, sterilization and biocompatibility

R. Gurny, M. Zignani, J. Heller, 1997 .

Investigations on the lyophilisation of MPEG-hexPLA micelle based pharmaceutical formulations.

R. Gurny, M. Möller, C. Di Tommaso, 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

In vitro dissolution medium with supramicellar surfactant concentration and its relevance for in vivo absorption

R. Gurny, B. Gander, K. Ventouras, 1985 .

Interaction of biodegradable nanoparticles with intestinal cells: the effect of surface hydrophilicity.

R. Gurny, M. Gaumet, F. Delie, 2010, International journal of pharmaceutics.

Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air.

N. Peppas, R. Gurny, E. Doelker, 1983, Journal of pharmaceutical sciences.

Distribution, kinetics and elimination of radioactivity after intravenous and intramuscular injection of 14C-savoxepine loaded poly(D,L-lactic acid) nanospheres to rats

R. Gurny, E. Allémann, E. Doelker, 1994 .

High throughput methods to characterize protein permeation and release.

R. Gurny, T. Arvinte, M. Capelle, 2008, International journal of pharmaceutics.

Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice.

R. Gurny, R. Cozens, J. Leroux, 1995, Journal of pharmaceutical sciences.

A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application.

R. Gurny, F. Behar-Cohen, D. Chauvaud, 2000, Journal of biomedical materials research.

Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester).

J. Veuthey, R. Gurny, M. Zignani, 1999, International journal of pharmaceutics.

Development and evaluation in vivo of a long-term delivery system for vapreotide, a somatostatin analogue.

R. Gurny, K. Besseghir, A. Rothen-Weinhold, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Solutions as solutions--synthesis and use of a liquid polyester excipient to dissolve lipophilic drugs and formulate sustained-release parenterals.

R. Gurny, M. Möller, Lutz R Asmus, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Polymeric Systems for Ophthalmic Drug Delivery

R. Gurny, O. Felt, V. Baeyens, 2001 .

In vitro and in vivo activities of verteporfin-loaded nanoparticles.

R. Gurny, E. Allémann, R. Boch, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Degrees of crystallinity and polymerization of modified cellulose powders for direct tableting

A. Jánosi, R. Gurny, J. Schurz, 1987 .

Pseudo-thermosetting chitosan hydrogels for biomedical application.

R. Gurny, J. Berger, M. Reist, 2005, International journal of pharmaceutics.

Development of poly(ortho esters) and their application for bovine serum albumin and bupivacaine delivery.

R. Gurny, M. van de Weert, J. Heller, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket.

R. Gurny, J. Heller, K. Schwach-Abdellaoui, 2001, Biomaterials.

Novel everolimus‐loaded nanocarriers for topical treatment of murine experimental autoimmune uveoretinitis (EAU)

A. Heiligenhaus, S. Thanos, R. Gurny, 2018, Experimental eye research.

A new drug delivery system inhibits uveitis in an animal model after cataract surgery.

K. Balaskas, R. Gurny, S. Eperon, 2013, International journal of pharmaceutics.

Trans-Scleral Diffusion of Triamcinolone Acetonide

R. Gurny, S. Eperon, Y. Guex-Crosier, 2005, Current eye research.

Novel self-associative and multiphasic nanostructured soft carriers based on amphiphilic hyaluronic acid derivatives.

M. Borkovec, R. Gurny, G. Kontogeorgis, 2012, Carbohydrate polymers.

Encapsulation of p‐THPP into Nanoparticles: Cellular Uptake, Subcellular Localization and Effect of Serum on Photodynamic Activity ¶

R. Gurny, E. Allémann, J. Chevallier, 2003, Photochemistry and photobiology.

Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing.

Y. Kalia, R. Gurny, F. Behar-Cohen, 2021, International journal of pharmaceutics.

Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localization.

R. Gurny, C. Stein, L. Benimetskaya, 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex.

R. Gurny, C. Stein, E. Allémann, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Determination of dexamethasone in tears by capillary electrophoresis.

J. Veuthey, R. Gurny, E. Varesio, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Novel micelle formulations to increase cutaneous bioavailability of azole antifungals.

Y. Kalia, R. Gurny, M. Möller, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Synthesis and ring‐opening polymerization of new monoalkyl‐substituted lactides

R. Gurny, M. Möller, T. Trimaille, 2004 .

Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides).

R. Gurny, M. Möller, K. Mondon, 2006, International journal of pharmaceutics.

Ocular therapy with nanoparticulate systems for controlled drug delivery

R. Gurny, H. Ibrahim, T. Boye, 1985 .

Cell interaction studies of PLA-MePEG nanoparticles.

R. Gurny, E. Allémann, E. Doelker, 2003, International journal of pharmaceutics.

Polymeric Nanoparticles for Drug Delivery to the Posterior Segment of the Eye

R. Gurny, F. Behar-Cohen, D. Benezra, 2005 .

Biocompatibility of a new semisolid bioerodible poly(ortho ester) intended for the ocular delivery of 5-fluorouracil.

R. Gurny, J. Anderson, S. F. Bernatchez, 1994, Journal of biomedical materials research.

Acute histopathological response to a new biodegradable polypeptidic polymer for implantable drug delivery system.

R. Gurny, J. Anderson, E. Doelker, 1989, Journal of biomedical materials research.

Intraocular Implants for Controlled Drug Delivery

R. Gurny, S. Erickson, F. Delie, 2008 .

A novel oxido-viscosifying Hyaluronic Acid-antioxidant conjugate for osteoarthritis therapy: biocompatibility assessments.

R. Gurny, L. Scapozza, M. Möller, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance.

J. Veuthey, D. Guillarme, R. Gurny, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infections in dogs.

R. Gurny, B. Boisramé, V. Baeyens, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Therapeutic applications of retinoids in ophthalmology

R. Gurny, P. Hughes, C. Tabatabay, 1997 .

Biological conversion of a water-soluble prodrug of cyclosporine A.

R. Gurny, F. Lallemand, E. Varesio, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations.

R. Gurny, V. Baeyens, 1997, Pharmaceutica acta Helvetiae.

Ocular tolerance of preservatives on the murine cornea.

R. Gurny, J. M. Mayer, B. Plazonnet, 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Ocular tolerance of preservatives and alternatives.

R. Gurny, J. Mayer, P. Furrer, 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.

Robert Gurny, Jean-Louis Bourges, R. Gurny, 2003, Investigative ophthalmology & visual science.

Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.

B Larijani, H E Junginger, M. Rafiee-Tehrani, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.

Robert Gurny, R. Gurny, Angelica Vargas, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Crosslinked poly(alkylene oxides) for the preparation of controlled release micromatrices

N. Peppas, R. Gurny, B. Gander, 1987 .

Effect of implantation site on outcome of tissue‐engineered vascular grafts

R. Gurny, J. Tille, B. Walpoth, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Chitosan: a unique polysaccharide for drug delivery.

P Buri, R. Gurny, O. Felt, 1998, Drug development and industrial pharmacy.

Current status in oral fluoride pharmacokinetics and implications for the prophylaxis against dental caries.

R. Gurny, P. Baehni, N. V. Castioni, 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications.

Robert Gurny, R. Gurny, J. Berger, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy.

R. Gurny, O. Felt, P. Buri, 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Salivary fluoride concentrations following applications of bioadhesive tablets and mouthrinses.

R. Gurny, V. Kaltsatos, P. Baehni, 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels

R. Gurny, M. Zignani, C. Tabatabay, 1995 .

Novel cyclosporin A formulations using MPEG-hexyl-substituted polylactide micelles: a suitability study.

R. Gurny, M. Möller, K. Mondon, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

PATENT LITERATURE REVIEW OF OPHTHALMIC INSERTS

Robert Gurny, Florian Gurtler, R. Gurny, 1995 .

Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers.

R. Gurny, F. Behar-Cohen, M. Möller, 2011, International journal of pharmaceutics.

Ocular tolerance of absorption enhancers in ophthalmic preparations

Robert Gurny, Pascal Furrer, R. Gurny, 2002, AAPS PharmSci.

Biodegradable polymers for the controlled release of ocular drugs

Robert Gurny, Cyrus Tabatabay, R. Gurny, 1998 .

A novel thermoresponsive hydrogel based on chitosan.

R. Gurny, O. Jordan, Yannic B. Schuetz, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

In vivo distribution and ex vivo permeation of cyclosporine A prodrug aqueous formulations for ocular application.

J. Veuthey, D. Guillarme, R. Gurny, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention.

Robert Gurny, Pascal Furrer, R. Gurny, 1999, International journal of pharmaceutics.

Design and evaluation of controlled release systems for the eye

Robert Gurny, C. G. Wilson, R. Gurny, 1987 .

Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis.

Y. Kalia, R. Gurny, M. Möller, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles.

Robert Gurny, Eric Allémann, R. Gurny, 2002, International journal of pharmaceutics.

Effect of Polymeric Network Structure on Drug Release from Cross-Linked Poly(Vinyl Alcohol) Micromatrices

N. Peppas, R. Gurny, B. Gander, 2004, Pharmaceutical Research.

Effects of the method of drug incorporation and the size of the monolith on drug release from cross-linked polymers

R. Gurny, B. Gander, E. Doelker, 1990 .

Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos.

R. Gurny, N. Lange, E. Debefve, 2004, International journal of pharmaceutics.

Microenvironmental pH and microviscosity inside pH-controlled matrix tablets: an EPR imaging study.

R. Gurny, H. Borchert, W. Herrmann, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Gamma scintigraphic study of precorneal drainage and assessment of miotic response in rabbits of various ophthalmic formulations containing pilocarpine

Robert Gurny, R. Gurny, P. Buri, 1993 .

Biomaterials in ophthalmic drug delivery

R. Gurny, M. Sintzel, S. F. Bernatchez, 1996 .

New surface-active polymers for ophthalmic formulations: evaluation of ocular tolerance.

Robert Gurny, Christel C Müller-Goymann, Pascal Furrer, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Gamma Sterilization of a Semi-Solid Poly(ortho ester) Designed for Controlled Drug Delivery—Validation and Radiation Effects

R. Gurny, J. Heller, A. Merkli, 1994, Pharmaceutical Research.

Influence of irradiation sterilization on a semi-solid poly(ortho ester)

Robert Gurny, Cyrus Tabatabay, Karsten Mäder, 1998 .

Influence of Irradiation Sterilization on Polymers Used as Drug Carriers—A Review

Robert Gurny, Cyrus Tabatabay, R. Gurny, 1997 .

Comparative studies of various hyaluronic acids produced by microbial fermentation for potential topical ophthalmic applications.

R. Gurny, P. Westh, K. Schwach-Abdellaoui, 2009, Journal of biomedical materials research. Part A.

Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin

R. Gurny, S. F. Bernatchez, C. Tabatabay, 1993, Graefe's Archive for Clinical and Experimental Ophthalmology.

Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers.

R. Gurny, P. Buri, A. Rozier, 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits.

R. Gurny, O. Camber, P. Edman, 1987, Current eye research.

In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration.

R. Gurny, P. Buri, G. Meseguer, 1994, Journal of drug targeting.

Latices and Thermosensitive Gels as Sustained Delivery Systems to the Eye

R. Gurny, P. Buri, H. Ibrahim, 1987 .

Mucoadhesive semi-solid formulations for intraoral use containing sucralfate

R. Gurny, R. Towart, P. Buri, 1996 .

A water-soluble prodrug of cyclosporine A for ocular application: a stability study.

R. Gurny, J. Marfurt, F. Lallemand, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.

R. Gurny, F. Behar-Cohen, F. Lallemand, 2006, Molecular vision.

A biodegradable drug delivery system for the treatment of postoperative inflammation.

R. Gurny, R Gurny, I. Petropoulos, 2008, International journal of pharmaceutics.

The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems.

Robert Gurny, Norbert Lange, R. Gurny, 2007, Advanced drug delivery reviews.

Cyclosporine A-Loaded Nanocarriers for Topical Treatment of Murine Experimental Autoimmune Uveoretinitis.

A. Heiligenhaus, S. Thanos, R. Gurny, 2018, Molecular pharmaceutics.

Confocal microscopy as a tool for the investigation of the anterior part of the eye.

Robert Gurny, Pascal Furrer, R. Gurny, 1997, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.

R. Gurny, F. Behar-Cohen, M. Berdugo, 2009, Investigative ophthalmology & visual science.

Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle

R. Gurny, O. Felt, V. Baeyens, 2001, AAPS PharmSci.

Therapeutic applications of viscous and injectable poly(ortho esters).

R. Gurny, F. Behar-Cohen, R Gurny, 2001, Advanced drug delivery reviews.

Poly(ortho esters) - their development and some recent applications.

R. Gurny, R Gurny, J. Heller, 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use

R. Gurny, O. Felt, P. Furrer, 2008 .

Conversion of cyclosporine A prodrugs in human tears vs rabbits tears.

S. Rudaz, R. Gurny, M. Mutter, 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy

R. Gurny, J. Ryser, O. Camber, 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy.

R. Gurny, R. Černý, E. Allémann, 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Coupling ultra high-pressure liquid chromatography with mass spectrometry: constraints and possible applications.

Davy Guillarme, Jean-Luc Veuthey, Robert Gurny, 2013, Journal of chromatography. A.

Physical instability, aggregation and conformational changes of recombinant human bone morphogenetic protein-2 (rhBMP-2).

Robert Gurny, Tudor Arvinte, Olivier Jordan, 2010, International journal of pharmaceutics.

Erratum to “Pseudo-thermosetting chitosan hydrogels for biomedical application”: [Int. J. Pharm. 288 (2005) 197–206]☆

R. Gurny, J. Berger, M. Reist, 2005 .

Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradation.

R. Gurny, J. Anderson, M. Zignani, 2000, Biomaterials.

Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model.

R. Gurny, J. Tille, B. Walpoth, 2012, Biomaterials.

Local delivery of antimicrobial agents for the treatment of periodontal diseases.

R. Gurny, K. Schwach-Abdellaoui, N. Vivien-Castioni, 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Subconjunctival biocompatibility of a viscous bioerodable poly(ortho ester).

R. Gurny, J. Anderson, M. Zignani, 1998, Journal of biomedical materials research.

Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defect.

Robert Gurny, Andrea Tami, Olivier Jordan, 2011, Journal of biomedical materials research. Part A.

Degradation and Healing Characteristics of Small-Diameter Poly(&egr;-Caprolactone) Vascular Grafts in the Rat Systemic Arterial Circulation

Robert Gurny, Afksendiyos Kalangos, A. Kalangos, 2008, Circulation.

Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye.

R. Gurny, F. Behar-Cohen, M. Savoldelli, 2002, Investigative ophthalmology & visual science.

Strategies for formulating and delivering poorly water-soluble drugs

J. Veuthey, D. Guillarme, R. Gurny, 2015 .

Sodium hyaluronate as a vehicle for an improved tolerance of 5-fluorouracil administered subconjunctivally to rabbits

R. Gurny, S. F. Bernatchez, C. Tabatabay, 1994 .

Semi-solid hydrophobic bioerodible poly(ortho ester) for potential application in glaucoma filtering surgery

Robert Gurny, Cyrus Tabatabay, Jorge Heller, 1994 .

The use of acidic and basic excipients in the release of 5-fluorouracil and mitomycin C from a semi-solid bioerodible poly(ortho ester)

R. Gurny, J. Heller, A. Merkli, 1995 .

Strategies to design push-pull osmotic systems for delivering low and pH-dependent soluble drugs

R. Gurny, J. Leroux, Docteur N. Loggia, 2018 .

Oral osmotically driven systems: 30 years of development and clinical use.

Joerg Ogorka, R. Gurny, Nicoletta Loggia, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Determination of pilocarpine by HPLC in presence of isopilocarpine a pH-sensitive polymer in ophthalmic dispersions.

R. Gurny, P. Buri, H. Ibrahim, 1987, Journal of pharmaceutical and biomedical analysis.

Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma.

Robert Gurny, Jean-Louis Bourges, Francine Behar-Cohen, 2008, Investigative ophthalmology & visual science.

Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod.

Y. Kalia, R. Gurny, M. Möller, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Colloidal Drug Delivery Systems - Recent Advances With Polymeric Micelles

R. Gurny, M. Möller, K. Mondon, 2008 .

Drug loaded poly(lactic acid) nanoparticles produced by a reversible salting-out process : purification of an injectable dosage form

Robert Gurny, E. Doelker, Eric Allémann, 1993 .

Validation of a novel molecular dynamics simulation approach for lipophilic drug incorporation into polymer micelles.

Giovanni M Pavan, Andrea Danani, Robert Gurny, 2012, The journal of physical chemistry. B.

MPEG‐hexPLA Micelles as Novel Carriers for Hypericin, a Fluorescent Marker for Use in Cancer Diagnostics

R. Gurny, M. Möller, K. Mondon, 2011, Photochemistry and photobiology.

High throughput screening of protein formulation stability: practical considerations.

Robert Gurny, Martinus A H Capelle, Tudor Arvinte, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Inhibition of HIV-1 in Cell Culture by Oligonucleotide-Loaded Nanoparticles

Robert Gurny, Eric Allémann, R. Gurny, 2001, Pharmaceutical Research.

Virosomal C. albicans vaccine for vaginal application: formulation development and toxicity/immunogenicity studies

R. Gurny, M. Amacker, G. Borchard, 2012 .

In Vivo Tissue-Engineered Vascular Grafts

R. Gurny, B. Nottelet, E. Pektok, 2020, Tissue-Engineered Vascular Grafts.

Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.

R. Gurny, N. Lange, A. So, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Formation of peptide impurities in polyester matrices during implant manufacturing.

D Jeannerat, R. Gurny, U. Burger, 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants.

R. Gurny, R Gurny, A Rothen-Weinhold, 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells.

R. Gurny, F. Buchegger, F Delie, 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Evaluation of the tablet core factors influencing the release kinetics and the loadability of push-pull osmotic systems.

Joerg Ogorka, R. Gurny, Nicoletta Loggia, 2009, Drug development and industrial pharmacy.

Influence of emulsifiers on film formation from cellulose acetate latexes. Modeling approach to the fate of emulsifiers in highly plasticized films. II

R. Gurny, E. Doelker, C. Bindschaedler, 1989 .

Influence of emulsifiers on film formation from cellulose acetate latexes experimental study of phase separation phenomena due to sodium dodecyl sulfate. I

R. Gurny, E. Doelker, C. Bindschaedler, 1987 .

Mechanically strong films produced from cellulose acetate latexes

R. Gurny, E. Doelker, C. Bindschaedler, 1987, The Journal of pharmacy and pharmacology.

Osmotic water transport through cellulose acetate membranes produced from a latex system.

R. Gurny, E. Doelker, C. Bindschaedler, 1987, Journal of pharmaceutical sciences.

Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH.

R. Gurny, B. Lueckel, Stefanie Siepe, 2006, International journal of pharmaceutics.

Terahertz pulsed imaging, a novel process analytical tool to investigate the coating characteristics of push-pull osmotic systems.

Robert Gurny, P. Taday, Joerg Ogorka, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Approach to design push-pull osmotic pumps.

Joerg Ogorka, R. Gurny, Nicoletta Loggia, 2009, International journal of pharmaceutics.

Evaluation of the Tablet Core Factors Influencing the Release Kinetics and the Loadability of Push–Pull Osmotic Systems

Joerg Ogorka, R. Gurny, Nicoletta Loggia, 2009 .

Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.

Robert Gurny, R. Gurny, M. Lück, 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles

R. Gurny, J. Kreuter, P. Speiser, 1986 .

Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates.

R. Gurny, T. Arvinte, Barthélemy Demeule, 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Detection and characterization of protein aggregates by fluorescence microscopy.

Robert Gurny, Tudor Arvinte, Barthélemy Demeule, 2007, International journal of pharmaceutics.

Assessment of tailor-made HPMC-based matrix minitablets comprising a weakly basic drug compound.

Robert Gurny, R. Gurny, Stefanie Siepe, 2008, Drug development and industrial pharmacy.

Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.

R. Gurny, F. Buchegger, N. Lange, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Current methods for attaching targeting ligands to liposomes and nanoparticles.

Robert Gurny, Eric Allémann, Franz Buchegger, 2004, Journal of pharmaceutical sciences.

Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer.

R. Gurny, N. Lange, M. Zeisser-Labouèbe, 2006, International journal of pharmaceutics.

Concept and development of ophthalmic pseudo-latexes triggered by pH

R. Gurny, E. Doelker, P. Buri, 1991 .

Controlled drug delivery with colloidal polymeric systems

R. Gurny, 1986 .

Recent advances in mucosal immunization using virus-like particles.

R. Gurny, G. Borchard, C. Moser, 2013, Molecular pharmaceutics.

Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.

R. Gurny, F. Buchegger, F Delie, 2007, International journal of pharmaceutics.

The Determination of the Entrapment Efficiency for a Molecular Dispersion System

Mario A. González, R. Gurny, G. S. Banker, 1979 .

Stability of human growth hormone: influence of methionine oxidation on thermal folding.

Robert Gurny, Martinus A H Capelle, Tudor Arvinte, 2011, Journal of pharmaceutical sciences.

Bioadhesion: Possibilities and Future Trends

Robert Gurny, Hans E. Junginger, H. Junginger, 1990 .

Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases.

R. Gurny, N. Lange, M. Zeisser-Labouèbe, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics.

R. Gurny, F. Lallemand, R Gurny, 2005, International journal of pharmaceutics.

[Relation between the structure of polymers and the controlled release of active ingredients].

N. Peppas, R. Gurny, 1983, Pharmaceutica acta Helvetiae.

In vitro drug release from self-catalyzed poly(ortho ester): case study of 5-fluorouracil.

R. Gurny, J. Heller, K. Schwach-Abdellaoui, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods.

Robert Gurny, Eric Allémann, Franz Buchegger, 2003, International journal of pharmaceutics.

Advantages of bilayered vascular grafts for surgical applicability and tissue regeneration.

R. Gurny, J. Tille, B. Walpoth, 2012, Acta biomaterialia.

Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site

R. Gurny, Min Zhao, I. Bravo-Osuna, 2017, Journal of controlled release : official journal of the Controlled Release Society.

Self-assembled polymeric nanocarriers for the targeted delivery of retinoic acid to the hair follicle.

Y. Kalia, R. Gurny, M. Möller, 2015, Nanoscale.

Poly(hexyl-substituted lactides): novel injectable hydrophobic drug delivery systems.

Robert Gurny, R. Gurny, M. Möller, 2007, Journal of biomedical materials research. Part A.

Oxidized recombinant human growth hormone that maintains conformational integrity.

S. Bell, R. Gurny, T. Arvinte, 2011, Journal of pharmaceutical sciences.

A novel biocompatible hyaluronic acid-chitosan hybrid hydrogel for osteoarthrosis therapy.

R. Gurny, L. Scapozza, A. Rougemont, 2015, International journal of pharmaceutics.

Polymeric Photosensitizer Prodrugs for Photodynamic Therapy

R. Gurny, N. Lange, M. Campo, 2007, Photochemistry and photobiology.

Enhanced physical stability of human calcitonin after methionine oxidation.

Robert Gurny, Martinus A H Capelle, Tudor Arvinte, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

In vitro and in vivo evaluation of progesterone implants based on new biodegradable poly(glutamic and glutamate esters) copolymers.

R. Gurny, E. Doelker, F. Lescure, 1995, Journal of biomaterials science. Polymer edition.

Effects on Gram-Negative and Gram-Positive Bacteria Mediated by 5-Aminolevulinic Acid and 5-Aminolevulinic Acid Derivatives

R. Gurny, N. Lange, N. Fotinos, 2008, Antimicrobial Agents and Chemotherapy.

Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation.

R. Gurny, P. Couvreur, M. Besnard, 2001, International journal of pharmaceutics.

A new poly(ortho ester)-based drug delivery system as an adjunct treatment in filtering surgery.

S. Rudaz, R. Gurny, F. Behar-Cohen, 2001, Investigative ophthalmology & visual science.

Basis for dosing time-dependent changes in the ocular and systemic absorption of topically applied timolol.

L. Balant, R. Gurny, H. Yamahara, 1996, Journal of Ocular Pharmacology and Therapeutics.

Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation.

R. Gurny, F. Behar-Cohen, M. Savoldelli, 2003, Journal of biomedical materials research. Part A.

Subconjunctival biocompatibility of poly ortho ester

R. Gurny, J. Anderson, M. Zignani, 1996 .

Synthesis and characterization of a new biodegradable semi-solid poly(ortho ester) for drug delivery systems.

R. Gurny, J. Heller, A. Merkli, 1993, Journal of biomaterials science. Polymer edition.

Establishment and first characterization of a sublingual epithelial and immune cell co-culture model.

R. Gurny, G. Borchard, Gaëlle Vacher, 2015, International journal of pharmaceutics.

Ocular biodistribution of spironolactone after single intravitreal injection of a biodegradable sustained release polymer in rats.

Y. Kalia, R. Gurny, F. Behar-Cohen, 2019, Molecular pharmaceutics.

Assessment of Tailor-Made HPMC-Based Matrix Minitablets Comprising a Weakly Basic Drug Compound

R. Gurny, B. Lueckel, Stefanie Siepe, 2008 .

LDDI 34(01).book(LDDI_A_248287.fm)

R. Gurny, B. Lueckel, Stefanie Siepe, 2008 .

Controlled and/or prolonged parental delivery of peptides from the hypothalmic pituitary axis

R. Gurny, A. Rothen-Weinhold, 1997 .

In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome.

M. Eid, R. Gurny, M. Fanchaouy, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting.

Robert Gurny, Eric Allémann, Franz Buchegger, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Recent advances in confocal microscopy for studying drug delivery to the eye: concepts and pharmaceutical applications.

Robert Gurny, Pascal Furrer, R. Gurny, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[Drug delivery systems for intraocular applications].

R. Gurny, F. Behar-Cohen, L. Kowalczuk, 2007, Journal francais d'ophtalmologie.

Characterization of protein aggregation: the case of a therapeutic immunoglobulin.

R. Gurny, A. Drake, M. Lawrence, 2007, Biochimica et biophysica acta.

New methods allowing the detection of protein aggregates

R. Gurny, G. Machaidze, T. Arvinte, 2009, mAbs.

An Open Pharmacokinetic Study of Hexylaminolevulinate-Induced Photodiagnosis after Intravesical Administration

R. Gurny, N. Lange, P. Jichlinski, 2006, Drugs in R&D.

Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer.

R. Gurny, M. Möller, G. Schwach, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Biodegradable PLGA microparticles for sustained release of a new GnRH antagonist: part II. In vivo performance.

Robert Gurny, R. Gurny, M. Lück, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Impact of Covalently Nile Red and Covalently Rhodamine Labeled Fluorescent Polymer Micelles for the Improved Imaging of the Respective Drug Delivery System.

R. Gurny, M. Möller, G. Borchard, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

5-ALA derivative-mediated photoinactivation of Propionibacterium acnes.

R. Gurny, N. Lange, N. Fotinos, 2009, Journal of dermatological science.

Hydrolysis and erosion studies of autocatalyzed Poly(ortho esters) containing lactoyl-lactyl acid dimers

R. Gurny, J. Heller, K. Schwach-Abdellaoui, 1999 .

Synthesis and characterization of self-catalyzed poly(ortho ester).

R. Gurny, M. S. Taylor, J. Heller, 1998, Biomaterials.

Bioerodible polymers for ocular drug delivery.

R. Gurny, J. Heller, A. Deshpande, 1998, Critical reviews in therapeutic drug carrier systems.

Purity and stability assessment of a semi-solid poly(ortho ester) used in drug delivery systems.

R. Gurny, R Gurny, J. Heller, 1996, Biomaterials.

Development and validation of a fast and sensitive UHPLC-ESI-MS method for the simultaneous quantification of spironolactone and its metabolites in ocular tissues.

Y. Kalia, R. Gurny, D. Gabriel, 2018, Biomedical chromatography : BMC.

Synthesis and analysis of viscous poly (ortho-ester) analogs for controlled drug release

R. Gurny, J. Heller, M. Sintzel, 1997 .

Encapsulation of p-THPP into Nanoparticles: Cellular Uptake, Subcellular Localization and Effect of Serum on Photodynamic Activity¶

R. Gurny, E. Allémann, J. Chevallier, 2003 .

Controlled delivery of metoclopramide using an injectable semi-solid poly(ortho ester) for veterinary application.

R. Gurny, Marc Schneider, K. Schwach-Abdellaoui, 2002, International journal of pharmaceutics.

Imaging tools for pharmaceutical development.

R. Gurny, K. Mäder, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[Matrices for controlled liberation of drugs from polymers. I. Mechanisms of the penetration of solvents into polymers].

R. Gurny, B. Gander, E. Doelker, 1986, Pharmaceutica acta Helvetiae.

Breaking the Aggregation of the Monoclonal Antibody Bevacizumab (Avastin®) by Dexamethasone Phosphate: Insights from Molecular Modelling and Asymmetrical Flow Field-Flow Fractionation

R. Gurny, L. Scapozza, Y. Westermaier, 2013, Pharmaceutical Research.

Association of ranibizumab (Lucentis®) or bevacizumab (Avastin®) with dexamethasone and triamcinolone acetonide: an in vitro stability assessment.

C. Pournaras, R. Gurny, C. Stella, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogue

R. Gurny, K. Besseghir, A. Rothen-Weinhold, 1997 .

[Composition, structure and physiologic parameters of the lacrimal system; implications for the concept of ophthalmic forms].

R. Gurny, P. Buri, H. Ibrahim, 1988, Pharmaceutica acta Helvetiae.

Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humans

R. Gurny, A. Mombelli, J. Heller, 2008, AAPS PharmSci.

A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release.

J. Veuthey, R. Gurny, J. Anderson, 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Biodegradable nanoparticles for direct or two-step tumor immunotargeting.

R. Gurny, F. Buchegger, E. Allémann, 2006, Bioconjugate chemistry.

Design and in vitro assessment of L-lactic acid-based copolymers as prodrug and carrier for intravitreal sustained L-lactate release to reverse retinal arteriolar occlusions.

C. Pournaras, A. Heiligenhaus, R. Gurny, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pulsatile Drug Delivery: Current Applications and Future Trends

N. Peppas, H. Junginger, R. Gurny, 1993 .

Injectable formulations for an intravitreal sustained-release application of a novel single-chain VEGF antibody fragment.

R. Gurny, M. Möller, J. Grimshaw, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Synthesis and characterization of self-catalyzed poly(ortho-esters) based on decanediol and decanediol-lactate.

R. Gurny, J. Heller, K. Schwach-Abdellaoui, 1999, Journal of Biomaterials Science. Polymer Edition.

Polymers in medicine III: C. Migliaresi, L. Nicolais, P. Guisti and E. Chiellini (eds.) Elsevier, Amsterdam, 1988, viii + 247 pages, Dfl. 180.00/$94.75.

R. Gurny, 1990 .

Fluorescence Correlation Spectroscopy for the Characterisation of Drug Delivery Systems

A. Zimmer, R. Gurny, F. Delie, 2001, Biological chemistry.

Stability studies of a somatostatin analogue in biodegradable implants.

R. Gurny, K. Besseghir, E. Sublet, 1999, International journal of pharmaceutics.

Paclitaxel-Eluting Biodegradable Synthetic Vascular Prostheses: A Step Towards Reduction of Neointima Formation?

Giuseppe Faggian, Alessandro Mazzucco, Robert Gurny, 2009, Circulation.

In vivo evaluation of hydrophilic and hydrophobic mucoadhesive semi-solid formulations containing sucralfate and lidocaine for intraoral use

R. Gurny, P. Buri, Y. Jacques, 1997 .

Controlled release veterinary drug delivery: biological and pharmaceutical considerations.

R. Gurny, M. Rathbone, 2000 .

A new high performance data acquisition system interfacing an instrumented tablet machine to a microcomputer

Robert Gurny, E. Doelker, A.-F. Rime, 1990 .

Ultraviolet Resonance Raman spectroscopy used to study formulations of salmon calcitonin, a starch-peptide conjugate and TGF-β3.

S E J Bell, S. Bell, R. Gurny, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

A High Throughput Protein Formulation Platform: Case Study of Salmon Calcitonin

Robert Gurny, Tudor Arvinte, Martinus A. H. Capelle, 2008, Pharmaceutical Research.

The use of drug-loaded nanoparticles in cancer chemotherapy

R. Gurny, J. Leroux, E. Doelker, 1996 .

Synthesis of a novel fluorescent poly(D,L-lactide) end-capped with 1-pyrenebutanol used for the preparation of nanoparticles.

R. Gurny, E. Allémann, E. Doelker, 2003, European Journal of Pharmaceutical Sciences.

Plasma treatment for improving cell biocompatibility of a biodegradable polymer scaffold for vascular graft applications.

R. Gurny, J. Tille, B. Walpoth, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Bioadhesive Drug Delivery Systems

V. Lenaerts, R. Gurny, 1989 .

pH-Sensitive Nanoparticles: An Effective Means to Improve the Oral Delivery of HIV-1 Protease Inhibitors in Dogs

R. Gurny, R. Cozens, J. Leroux, 1996, Pharmaceutical Research.

Terahertz pulsed imaging, a novel process analytical tool to investigate the coating characteristics of push-pull osmotic systems.

P. Taday, Joerg Ogorka, R. Gurny, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics.

R. Gurny, J. Leroux, E. Allémann, 1998, Advanced drug delivery reviews.

Thermodynamics of swelling of polymer latex particles by a water-soluble solvent: I. Theoretical considerations

N. Peppas, R. Gurny, E. Doelker, 1985 .

Paclitaxel-Eluting Biodegradable Synthetic Vascular Prostheses

G. Faggian, A. Mazzucco, A. Kalangos, 2009 .

In vivo biocompatibility, sustained-release and stability of triptorelin formulations based on a liquid, degradable polymer.

R. Gurny, J. Tille, M. Möller, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis.

Y. Kalia, R. Gurny, M. Möller, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications.

N. Peppas, R. Gurny, J. Berger, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Ocular biocompatibility of novel Cyclosporin A formulations based on methoxy poly(ethylene glycol)-hexylsubstituted poly(lactide) micelle carriers.

R. Gurny, F. Behar-Cohen, M. Möller, 2011, International journal of pharmaceutics.

Release of BSA from poly(ortho ester) extruded thin strands.

R. Gurny, R Gurny, J. Heller, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Ocular drug delivery in veterinary medicine.

Deshpande, R. Gurny, M. Zignani, 1997, Advanced drug delivery reviews.

Breaking the Aggregation of the Monoclonal Antibody Bevacizumab (Avastin®) by Dexamethasone Phosphate: Insights from Molecular Modelling and Asymmetrical Flow Field-Flow Fractionation

R. Gurny, L. Scapozza, Y. Westermaier, 2013, Pharmaceutical Research.

In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.

J. Veuthey, D. Guillarme, R. Gurny, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

A new biocompatible drug delivery system for chronic implantation in animal brain.

R. Gurny, S. P. Simmons, R. Meeker, 1979, Pharmaceutica acta Helvetiae.

Solutions for Lipophilic Drugs: A Biodegradable Polymer Acting as Solvent, Matrix, and Carrier to Solve Drug Delivery Issues

R. Gurny, M. Möller, Lutz R Asmus, 2011, The International journal of artificial organs.